Gufic Bio Sciences Ltd., a leading player in the pharmaceutical industry, is pleased to announce the appointment of Mr. Rajasekar as the new President – International Business, effective January 14th, 2025.
Mr. Rajasekar, a seasoned Senior Management professional, brings with him over 29+ years of experience in exports, P&L management, and leadership across a wide range of organizations. Known for his performance-driven leadership, he has successfully led global pharmaceutical companies and fostered a culture centered on values, mentoring teams, and driving sustainable growth.
With expertise spanning regions such as the USA, Latin America, the Middle East, Asia, Africa, and the EU, Mr. Rajasekar is an expert in global pharmaceutical operations. He is renowned for his strategic mindset, exceptional change management capabilities, and ability to expand corporate presence in emerging and competitive markets. His proven track record includes leading business development, licensing efforts, and defining strategic action plans to enhance market presence.
Mr. Rajasekar’s leadership roles in companies such as SKF – Bangladesh, PT Sanbe Farma – Indonesia, Emcure, Macleods, IPCA, Smith Kline Beecham & Pfizer have been pivotal in driving growth and establishing strong international partnerships. The youngest member of the SB Academy in the UK..
Mr. Rajasekar holds a Bachelor’s degree in Science from MK University, a Post Graduate Diploma in Business Management from IMT, and a Doctorate from Anna University.
At Gufic Bio Sciences Ltd., Mr. Rajasekar will play a critical role in overseeing the company’s international business strategy and enhancing its global footprint, further solidifying Gufic’s presence in the international pharmaceutical market.